A detailed history of Blair William & CO transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Blair William & CO holds 1,173,058 shares of IDXX stock, worth $508 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
1,173,058
Previous 1,189,144 1.35%
Holding current value
$508 Million
Previous $642 Million 10.99%
% of portfolio
1.79%
Previous 2.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$468.04 - $548.53 $7.53 Million - $8.82 Million
-16,086 Reduced 1.35%
1,173,058 $572 Million
Q1 2024

May 09, 2024

SELL
$515.08 - $576.87 $6.24 Million - $6.98 Million
-12,107 Reduced 1.01%
1,189,144 $642 Million
Q4 2023

Feb 12, 2024

BUY
$391.37 - $557.56 $511,129 - $728,173
1,306 Added 0.11%
1,201,251 $667 Million
Q3 2023

Nov 09, 2023

BUY
$432.42 - $556.67 $3.38 Million - $4.35 Million
7,812 Added 0.66%
1,199,945 $525 Million
Q2 2023

Aug 11, 2023

SELL
$450.7 - $503.61 $7.69 Million - $8.59 Million
-17,061 Reduced 1.41%
1,192,133 $599 Million
Q1 2023

May 12, 2023

BUY
$406.01 - $514.59 $1.4 Million - $1.77 Million
3,437 Added 0.29%
1,209,194 $605 Million
Q4 2022

Feb 10, 2023

SELL
$324.64 - $441.27 $6.2 Million - $8.43 Million
-19,111 Reduced 1.56%
1,205,757 $492 Million
Q3 2022

Nov 09, 2022

SELL
$325.8 - $407.78 $1.9 Million - $2.37 Million
-5,819 Reduced 0.47%
1,224,868 $399 Million
Q2 2022

Aug 10, 2022

SELL
$327.37 - $553.44 $8.29 Million - $14 Million
-25,334 Reduced 2.02%
1,230,687 $432 Million
Q1 2022

May 13, 2022

SELL
$466.52 - $631.01 $15.9 Million - $21.5 Million
-34,011 Reduced 2.64%
1,256,021 $687 Million
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $2.27 Million - $2.58 Million
-3,871 Reduced 0.3%
1,290,032 $849 Million
Q3 2021

Nov 12, 2021

SELL
$621.9 - $705.76 $34.9 Million - $39.6 Million
-56,062 Reduced 4.15%
1,293,903 $805 Million
Q2 2021

Aug 12, 2021

SELL
$486.36 - $637.08 $19.6 Million - $25.6 Million
-40,231 Reduced 2.89%
1,349,965 $853 Million
Q1 2021

May 13, 2021

SELL
$465.18 - $551.79 $41.1 Million - $48.8 Million
-88,432 Reduced 5.98%
1,390,196 $680 Million
Q4 2020

Feb 09, 2021

SELL
$383.85 - $499.87 $12.4 Million - $16.1 Million
-32,211 Reduced 2.13%
1,478,628 $739 Million
Q3 2020

Nov 06, 2020

SELL
$334.54 - $406.31 $13.7 Million - $16.6 Million
-40,835 Reduced 2.63%
1,510,839 $594 Million
Q2 2020

Aug 12, 2020

SELL
$230.66 - $330.16 $2.67 Million - $3.82 Million
-11,580 Reduced 0.74%
1,551,674 $512 Million
Q1 2020

May 11, 2020

BUY
$182.94 - $290.97 $3.16 Million - $5.03 Million
17,274 Added 1.12%
1,563,254 $379 Million
Q4 2019

Feb 13, 2020

SELL
$248.66 - $285.01 $49,483 - $56,716
-199 Reduced 0.01%
1,545,980 $404 Million
Q3 2019

Nov 12, 2019

SELL
$260.07 - $289.93 $7.14 Million - $7.96 Million
-27,469 Reduced 1.75%
1,546,179 $420 Million
Q2 2019

Aug 13, 2019

SELL
$215.53 - $275.33 $1.85 Million - $2.36 Million
-8,574 Reduced 0.54%
1,573,648 $433 Million
Q1 2019

May 14, 2019

BUY
$178.02 - $225.69 $1.88 Million - $2.39 Million
10,586 Added 0.67%
1,582,222 $354 Million
Q4 2018

Feb 14, 2019

BUY
$176.18 - $248.92 $5.91 Million - $8.35 Million
33,525 Added 2.18%
1,571,636 $292 Million
Q3 2018

Nov 13, 2018

SELL
$218.82 - $254.46 $7.94 Million - $9.23 Million
-36,279 Reduced 2.3%
1,538,111 $384 Million
Q2 2018

Aug 13, 2018

SELL
$185.56 - $227.9 $8.45 Million - $10.4 Million
-45,549 Reduced 2.81%
1,574,390 $343 Million
Q1 2018

May 15, 2018

SELL
$157.81 - $204.73 $25.4 Million - $33 Million
-161,215 Reduced 9.05%
1,619,939 $310 Million
Q4 2017

Feb 14, 2018

SELL
$147.68 - $168.37 $89,494 - $102,032
-606 Reduced 0.03%
1,781,154 $279 Million
Q3 2017

Nov 13, 2017

BUY
$150.32 - $166.46 $268 Million - $297 Million
1,781,760
1,781,760 $277 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $36B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.